Novamont to purchase 78% stake in Italy-based Mossi and Ghisolfi subsidiary Mater-Biopolymer; company may acquire remaining shares by end of 2016

Elyse Blye

Elyse Blye

Mar 19, 2014 – Chimie Pharma Hebdo (CBNB Abstracts)

March 19, 2014 () – Novamont has signed an agreement to acquire a 78% stake in Mater-Biopolymer, a subsidiary of Mossi and Ghisolfi (M&G). It may acquire the remaining shares by the end of 2016. Mater-Biopolymer runs a facility at Patrica, Italy. The firm will continue to produce on behalf of Novamont and M&G . One of its production lines produces Origo-Bi, a range of polyesters using biomonomers provided by Novamont. A second production line will continue to produce PET for M&G until it is converted to Origo-Bi. The Patrica site could produce almost 100,000 tonnes/y of Origo-Bi polyesters.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025 795

+1 (310) 558 0008
+1 (310) 558 0080 (FAX)

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.